MindX Sciences
Products
Solutions
Science
Company
Contact
Order
Open menu
It appears JavaScript is disabled in your browser. Some features of this site require JavaScript. Your user experience may be degraded.
Patents
Issued and allowed patents.
Patent
Issued
Patent ID
MindX One Certificate of Registration
07-14-2026
98381174
Methods for Objective Assessment of Memory, Early Detection of Risk for Alzheimer‘s Disease, Matching Individuals with Treatments, Monitoring Response to Treatments, and New Methods for Use for Drugs.
03-10-2026
US-12,569,483-B2
Methods for Objective Assessment of Stress, Early Detection of Risk for Stress Disorders, Matching Individuals with Treatments, Monitoring Response to Treatment, and New Methods of Use for Drugs.
01-20-2026
US-12,529,704-B2
Precision Medicine for Pain; Diagnostic Biomarkers, Pharmacogenomics, and Repurposed Drugs (Australia)
09-04-2025
AU 2019235923
Predicting Suicidality Using A Combined Genomic and Clinical Risk Assessment (Europe)
10-30-2024
EP 3307910
Precision Medicine for Pain; Diagnostic Biomarkers, Pharmacogenomics, and Repurposed Drugs (Europe)
08-27-2024
EP 3765630
Precision Medicine for Pain; Diagnostic Biomarkers, Pharmacogenomics, and Repurposed Drugs (Japan)
05-20-2024
JP 7491847B2
Precision Medicine for Treating and Preventing Suicidality
03-21-2023
US-11,608,532-B2
Drugs, Pharmacogenomics and Biomarkers for Active Longevity
08-06-2022
EP 3 433 380 B1
Blood Biomarkers for Suicidality
06-29-2021
US-11,047,009-B2
Predicting Suicidality Using A Combined Genomic and Clinical Risk Assessment
04-27-2021
US-10,991,449-B2
Precision Medicine for Schizophrenia and Psychotic Disorders: Objective Assessment, Risk Prediction, Pharmacogenomics, and Repurposed Drugs
Notice of Allowance
US 2022-0403469
Precision Medicine for Pain; Diagnostic Biomarkers, Pharmacogenomics, and Repurposed Drugs (Israel)
Notice of Allowance
IL 277000
Predicting Suicidality Using A Combined Genomic and Clinical Risk Assessment (Canada)
Notice of Allowance
CA 2988578
A series of other patents are pending in various jurisdictions.
Certifications
Publications
Pipeline
News
Ask Max